• TB Outbreaks Could be 'Solved' by DNA Tracking
    Reconstructing the spread of killer diseases such as tuberculosis (TB) from person to person using DNA sequencing quickly identifies the origin and movement of pathogens. This approach is directly informing public health strategies to control infectious disease outbreaks, ...More
    September 4, 2012 Posted in News
  • Integration of Active Tuberculosis Case Finding in a Mobile HIV-Testing Clinic is Feasible
    A research article by Katharina Kranzer from the London School of Hygiene & Tropical Medicine and colleagues describe the feasibility and costs of an active tuberculosis case finding project in Cape Town, South Africa. The study describes the integration of tuberculosis ...More
    August 8, 2012 Posted in News
  • Researchers Call for Change in New FDA Recommendation on HIV and TB Drug Doses
    In January, 2012, the Food and Drug Administration (FDA) issued new guidelines on dosing of an HIV medication used to treat people infected with both HIV and tuberculosis (TB) because of a potential interaction between two of the main drugs used to treat each disease. The ...More
    July 24, 2012 Posted in News
  • Package Inserts Overstate Diagnostic TB Tests' Accuracy
    Clinicians and laboratory professionals often rely on manufacturers' package inserts to assess the accuracy of diagnostic medical tests. However, package inserts frequently greatly overstate such tests' accuracy, according to a case study of package inserts for tuberculosis ...More
    July 18, 2012 Posted in News
  • Nurse Hits the Road to Combat Infectious Disease
    Her passport is stamped with exotic locations: Myanmar, Tibet, South Africa, Vietnam, and Cambodia, as well as Baltimore, MD. But, when Carrie Tudor, PhD, MPH, RN, looks at it, she sees global battlefields in the fight against infectious disease. Her weapons: immunizations, ...More
    July 13, 2012 Posted in News
  • Millions of Diabetics Could Die of Tuberculosis
    One-third of the world’s human population is infected with a dormant tuberculosis bacteria, primarily people living in developing countries. The bacteria presents a lifelong TB risk. Recent research out of the University of Copenhagen demonstrates that the risk of ...More
    July 9, 2012 Posted in News
  • TB Treatment Paradox: Mouse Studies Show Body's Own Response Helps TB Bacteria Survive
    Inhibiting a key immune response in mice during initial multi-drug treatment for tuberculosis could — paradoxically — shorten treatment time for the highly contagious lung infection according to new research from Johns Hopkins Children's Center and the Center for TB ...More
    June 28, 2012 Posted in News
  • Growing Presence of Drug-Resistant TB Fuels Need for More Screening, Faster Testing
    Johns Hopkins experts in the prevention and treatment of multidrug-resistant tuberculosis are calling for increased screening and more rapid testing of the 9 million people worldwide estimated to be infected each year with TB and now at risk for this form of the highly ...More
    June 7, 2012 Posted in News
  • College Awarded Grant to Develop New TB Vaccine Against Drug-Resistant Strains
    The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as ...More
    May 31, 2012 Posted in News
  • Targeting Tuberculosis Hotspots Could Have Widespread Benefit
    Reducing tuberculosis transmission in geographic "hotspots" where infections are highest could significantly reduce TB transmission on a broader scale, according to a study led by researchers at the Johns Hopkins Bloomberg School of Public Health. An analysis of data from ...More
    May 28, 2012 Posted in News